John K. Triantafillidis

Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.

John K. Triantafillidis, P. Kosmidis · PubMed · 2009 · 426 citations

Prevention Strategies, Cancer Epidemiology, Gastrointestinal Oncology +13

Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome

Père Clavé, Monica Acalovschi, John K. Triantafillidis et al. · Alimentary Pharmacology & Therapeutics · 2011 · 109 citations · Full text

Impact of beta-glucan on the faecal microbiota of polypectomized patients: A pilot study

Katja Turunen, E. Tsouvelakidou, Tz. Nomikos et al. · Anaerobe · 2011 · 47 citations

Probiotic, Dysbiosis, Medicine +10

Clinical Patterns of Crohn’s Disease in Greece: A Follow-Up Study of 155 Cases

John K. Triantafillidis, Anastasios Emmanouilidis, Orestis Manousos et al. · Digestion · 2000 · 47 citations

Functional Gastrointestinal Disorder, Follow-up Study, Familial Clustering +11

Antioxidative Efficacy of a Pistacia Lentiscus Supplement and Its Effect on the Plasma Amino Acid Profile in Inflammatory Bowel Disease: A Randomised, Double-Blind, Placebo-Controlled Trial

Efstathia Papada, Alastair Forbes, Charalampia Amerikanou et al. · Nutrients · 2018 · 44 citations · Full text